Cantor Fitzgerald Starts Acacia Research (ACTG) at Buy; The Greenest Thumb in Patent-land
Tweet
Share
E-mailGet Alerts ACTG Hot Sheet
Price: $4.51 --0%
Rating Summary:
7 Buy, 0 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Rating Summary:
7 Buy, 0 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Join SI Premium – FREE
Cantor Fitzgerald initiates coverage on Acacia Research (NASDAQ: ACTG) with a Buy. PT $45.00.
Cantor analyst says, "Until recently, patents have been a defensive asset class, used principally as an impassive insurance policy for its holder's core business, with rights-assertion (costly and risky litigation) being an unsavory last resort. However, Acacia has since demonstrated that patents can be monetized with increasing ease, little risk, and no capital intensity. Thus, a virtuous cycle has evolved, where IP holders (small and increasingly large) partner with ACTG to unlock IP value, while larger companies increasingly settle and/or preemptively license Acacia's burgeoning patent portfolio. Along these lines, ACTG's 192 IP portfolios and 1,050 agreements, have generated $500M+ in licensing revenues, while Oracle (Nasdaq: ORCL), Microsoft (Nasdaq: MSFT), and Samsung have already signed comprehensive IP litigation-protection agreements (span a few years)."
For an analyst ratings summary and ratings history on Acacia Research click here. For more ratings news on Acacia Research click here.
Shares of Acacia Research closed at $30.69 yesterday.
Cantor analyst says, "Until recently, patents have been a defensive asset class, used principally as an impassive insurance policy for its holder's core business, with rights-assertion (costly and risky litigation) being an unsavory last resort. However, Acacia has since demonstrated that patents can be monetized with increasing ease, little risk, and no capital intensity. Thus, a virtuous cycle has evolved, where IP holders (small and increasingly large) partner with ACTG to unlock IP value, while larger companies increasingly settle and/or preemptively license Acacia's burgeoning patent portfolio. Along these lines, ACTG's 192 IP portfolios and 1,050 agreements, have generated $500M+ in licensing revenues, while Oracle (Nasdaq: ORCL), Microsoft (Nasdaq: MSFT), and Samsung have already signed comprehensive IP litigation-protection agreements (span a few years)."
For an analyst ratings summary and ratings history on Acacia Research click here. For more ratings news on Acacia Research click here.
Shares of Acacia Research closed at $30.69 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
- BMO Capital Starts Broadcom Limited (AVGO) at Outperform
- BMO Capital Starts Analog Devices (ADI) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
